REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David M. Weinreich, George D. Yancopoulos, Sumathi Sivapalasingam et al.|New England Journal of Medicine|2020Cited by 1.8k
REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 OutpatientsDavid M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al.|medRxiv|2021Cited by 40
All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the <scp>HALLMARK DUAL</scp> studyJia‐Horng Kao, Stephanie Noviello, Eric Hughes et al.|Liver International|2016Cited by 28
REGEN-COV Antibody Combination in Outpatients With COVID-19 – Phase 1/2 ResultsThomas Norton, Shazia Ali, Sumathi Sivapalasingam et al.|medRxiv|2021Cited by 19
Daclatasvir plus asunaprevir for <scp>HCV</scp> genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysisJia‐Horng Kao, Stephanie Noviello, Donald M. Jensen et al.|Liver International|2015Cited by 16